← Back to Search

Multi-Level Intervention for Colorectal Cancer Screening (ACCSIS Trial)

N/A
Waitlist Available
Led By Mark B Dignan, PhD
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 50-74
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a multi-level intervention can increase colorectal cancer screening rates in 12 counties in Appalachian Kentucky and Ohio.

Who is the study for?
This trial is for residents aged 50-74 in certain Appalachian counties of Kentucky and Ohio, regardless of their race, sex, or gender. It aims to help increase colorectal cancer screening rates in these communities.
What is being tested?
The study tests a multi-level intervention designed to boost colorectal cancer screenings by involving clinics, providers, patients, and the community. Half the counties start early while the other half begin later to compare effectiveness.
What are the potential side effects?
Since this trial focuses on increasing screening rather than testing a medical product or drug, it does not have direct side effects like those associated with medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 74 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
CRC screening - clinic level
Secondary study objectives
CRC screening - community level

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multi-level InterventionExperimental Treatment1 Intervention
Receives the project intervention first
Group II: Delayed Multi-level InterventionActive Control1 Intervention
Offered the intervention later in the project

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,017,745 Total Patients Enrolled
University of KentuckyLead Sponsor
194 Previous Clinical Trials
218,275 Total Patients Enrolled
Ohio State UniversityOTHER
871 Previous Clinical Trials
650,037 Total Patients Enrolled
Mark B Dignan, PhDPrincipal InvestigatorUniversity of Kentucky

Media Library

Multi-level intervention to increase CRC screening Clinical Trial Eligibility Overview. Trial Name: NCT04427527 — N/A
Colorectal Cancer Clinical Trial 2023: Multi-level intervention to increase CRC screening Highlights & Side Effects. Trial Name: NCT04427527 — N/A
Multi-level intervention to increase CRC screening 2023 Treatment Timeline for Medical Study. Trial Name: NCT04427527 — N/A
Colorectal Cancer Research Study Groups: Delayed Multi-level Intervention, Multi-level Intervention
~296 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top